Since the 1970s, the federal government has listed the active ingredients in mushrooms-;psilocybin and psilocin-;as illegal and having no accepted medical use.
Mar 18 2024University of Texas at Arlington
Clinicians now find themselves needing to carefully measure the doses of mushrooms to ensure patients receive the proper amount during treatment. To solve this problem, University of Texas at Arlington researchers have created a method to determine the clinical potency of psilocybin and psilocin in the hallucinogenic mushroom species psilocybe cubensis.
Kevin Schug, the Shimadzu Distinguished Professor of Analytical Chemistry in the Department of Chemistry and Biochemistry
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
House 'frozen in 1970s' with orange sofas is a real trip back in timePerched on top of a small hill, a set of stone steps lead up past a large garage
Read more »
The best adverts of the 1970sAntonia Wilson is a freelance writer and editor. Previous roles have included travel reporter for the Guardian, and staff writer for Creative Review magazine, alongside writing for The Observer, National Geographic Traveller, Essentialist and Eco-Age, among others.
Read more »
This Artist Took One Self-Portrait Every Day in 1970s New YorkKristina Shook talks about her mother Melissa Shook’s Daily Self-Portraits (1972–1973) series, which offers an expansive and inviting meditation on womanhood
Read more »
Why oil supply shocks are not like the 1970s any moreAmerica has a lot of oil now, and the global energy market is more robust
Read more »
Researchers pinpoint issue that could be hampering common chemotherapy drugResearchers at the University of Toronto's Donnelly Centre for Cellular and Biomolecular Research have found two enzymes that work against the chemotherapy drug gemcitabine, preventing it from effectively treating pancreatic cancer.
Read more »
Researchers find branched chain amino acid supplementation may aid in concussion recoveryIn the first clinical trial of a targeted pharmacologic therapeutic for mild traumatic brain injury in pediatric patients, scientists from the Minds Matter Concussion Frontier Program at Children's Hospital of Philadelphia (CHOP) have found preliminary evidence that adolescents and young adults with concussion who take a specific formulation of...
Read more »